Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
Daniele Pala, Marco Pistis
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease
Ricarda Cortés-Vieyra, Sergio Gutiérrez‐Castellanos, Cleto Álvarez-Aguilar, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1675-1675
Open Access | Times Cited: 33
Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae
Gustavo Ramírez-Martínez, Luis Jiménez-Álvarez, Alfredo Cruz‐Lagunas, et al.
Journal of Interferon & Cytokine Research (2022) Vol. 42, Iss. 8, pp. 352-368
Open Access | Times Cited: 24
Emerging Evidence for Pleiotropism of Eosinophils
José M. Rodrigo‐Muñoz, Marta Gil‐Martínez, Beatriz Sastre, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7075-7075
Open Access | Times Cited: 32
Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models
Hao Wang, Damon J. Tumes, Timothy R. Hercus, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 22
Exploring Asthma as a Protective Factor in COVID-19 Outcomes
Anthony E. Quinn, Lei Zhao, Scott D. Bell, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1678-1678
Open Access
Immune dysregulation in long covid may contribute to the development of neurological disorders through the effects of cytokines
В. В. Рассохин, N. A. Аrsentieva, Zoia R. Korobova, et al.
HIV Infection and Immunosuppressive Disorders (2025) Vol. 16, Iss. 4, pp. 7-16
Open Access
Antiviral roles of eosinophils in asthma and respiratory viral infection
Hisashi Sasaki, Jun Miyata, Akihiko Kawana, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety
W. Sahli, Joana Vitte, Benoît Desnues
Clinical and Translational Allergy (2025) Vol. 15, Iss. 3
Open Access
COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
Biswajit Biswas, Shagnik Chattopadhyay, Sayantee Hazra, et al.
Inflammation Research (2022) Vol. 71, Iss. 4, pp. 377-396
Open Access | Times Cited: 18
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
Andriana Ι. Papaioannou, Evangelia Fouka, Νikolaos Tzanakis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 10, pp. 2588-2595
Open Access | Times Cited: 17
Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
Claudia Vanetti, Marta Stracuzzi, Elisa Crivellaro, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook
Arneaux Kruger, David Joffe, Graham Lloyd‐Jones, et al.
Seminars in Thrombosis and Hemostasis (2024)
Open Access | Times Cited: 3
Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
Dimitri Poddighe, Elena Kovzel
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6845-6853
Open Access | Times Cited: 23
Cellular immune states in SARS-CoV-2-induced disease
Keywan Mortezaee, Jamal Majidpoor
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice
Qing Huang, Ran An, Haixuan Wang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study
Sara Manti, Alessandro Giallongo, Giulia Pecora, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 4, pp. 1085-1091
Closed Access | Times Cited: 7
Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model
Colleen S. Curran, Xizhong Cui, Yan Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 2
Monocentric study of IL-5 monoclonal antibody induction therapy for eosinophilic granulomatosis with polyangiitis
Chrong‐Reen Wang, Hung‐Wen Tsai, Chi‐Chang Shieh
Journal of the Formosan Medical Association (2024) Vol. 123, Iss. 7, pp. 802-810
Open Access | Times Cited: 2
COVID-19, Eosinophils, and Biologicals for Severe Asthma
Carlo Lombardi, Diego Bagnasco, Giovanni Passalacqua
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 10
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability
Dorian Forte, Roberto Maria Pellegrino, Sara Trabanelli, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-14
Open Access | Times Cited: 5
Impact of social distancing from the COVID-19 pandemic on the immuno-inflammatory response of older adults
Giulia Beletato Nery, Carlos Ariel Rodrigues de Araújo, Giovanna Beatriz da Silva, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Biologics may have a beneficial effect in asthma patients with COVID-19
José Luis Izquierdo, Joan B. Soriano
European Respiratory Journal (2021) Vol. 58, Iss. 2, pp. 2101076-2101076
Open Access | Times Cited: 8
Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China
Junyi Jiang, Weijun Zhong, Wei‐Hua Huang, et al.
Therapeutics and Clinical Risk Management (2022) Vol. Volume 18, pp. 579-591
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top